These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Ocular signs of canine monocytic ehrlichiosis: a retrospective study in dogs from Barcelona, Spain. Leiva M; Naranjo C; Peña MT Vet Ophthalmol; 2005; 8(6):387-93. PubMed ID: 16359361 [TBL] [Abstract][Full Text] [Related]
23. Development of polyvinyl alcohol-gelatin membranes for antibiotic delivery in the eye. Jain D; Carvalho E; Banthia AK; Banerjee R Drug Dev Ind Pharm; 2011 Feb; 37(2):167-77. PubMed ID: 21073319 [TBL] [Abstract][Full Text] [Related]
24. Research review and update: IQUIX (levofloxacin 1.5%). McDonald MB Int Ophthalmol Clin; 2006; 46(4):47-60. PubMed ID: 17060791 [No Abstract] [Full Text] [Related]
25. Immunomodulating agents. Moore CP Vet Clin North Am Small Anim Pract; 2004 May; 34(3):725-37. PubMed ID: 15110981 [TBL] [Abstract][Full Text] [Related]
26. Use of azithromycin ophthalmic solution in the treatment of chronic mixed anterior blepharitis. John T; Shah AA Ann Ophthalmol (Skokie); 2008; 40(2):68-74. PubMed ID: 19013912 [TBL] [Abstract][Full Text] [Related]
27. Antiviral therapy for ocular viral disease. Galle LE Vet Clin North Am Small Anim Pract; 2004 May; 34(3):639-53. PubMed ID: 15110976 [TBL] [Abstract][Full Text] [Related]
28. Nonhypotensive autonomic agents in veterinary ophthalmology. Klauss G; Constantinescu GM Vet Clin North Am Small Anim Pract; 2004 May; 34(3):777-800. PubMed ID: 15110984 [TBL] [Abstract][Full Text] [Related]
29. Isolation of obligate anaerobic bacteria from ulcerative keratitis in domestic animals. Ledbetter EC; Scarlett JM Vet Ophthalmol; 2008; 11(2):114-22. PubMed ID: 18302576 [TBL] [Abstract][Full Text] [Related]
30. Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans. Robertson SM; Curtis MA; Schlech BA; Rusinko A; Owen GR; Dembinska O; Liao J; Dahlin DC Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S32-45. PubMed ID: 16257309 [TBL] [Abstract][Full Text] [Related]
31. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers. Torkildsen G; O'Brien TP Clin Ther; 2008 Nov; 30(11):2005-14. PubMed ID: 19108788 [TBL] [Abstract][Full Text] [Related]
32. Ocular hypotensive drugs. Willis AM Vet Clin North Am Small Anim Pract; 2004 May; 34(3):755-76. PubMed ID: 15110983 [TBL] [Abstract][Full Text] [Related]
33. Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Del Amo EM; Urtti A Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911 [TBL] [Abstract][Full Text] [Related]
34. Restricting topical ocular chloramphenicol eye drop use in the United States. Did we overreact? Fraunfelder FW; Fraunfelder FT Am J Ophthalmol; 2013 Sep; 156(3):420-422. PubMed ID: 23953152 [No Abstract] [Full Text] [Related]
38. Post-marketing surveillance of levofloxacin 0.5% ophthalmic solution for external ocular infections. Kanda Y; Kayama T; Okamoto S; Hashimoto M; Ishida C; Yanai T; Fukumoto M; Kunihiro E Drugs R D; 2012 Dec; 12(4):177-85. PubMed ID: 23075336 [TBL] [Abstract][Full Text] [Related]
39. Intracameral antibiotics: questions for the United States based on prospective studies. Liesegang TJ J Cataract Refract Surg; 2008 Mar; 34(3):505-9. PubMed ID: 18299079 [TBL] [Abstract][Full Text] [Related]
40. The 'up-down' sign of acute ocular surface drug toxicity. Dua HS; Otri AM; Said DG; Faraj LA Br J Ophthalmol; 2012 Nov; 96(11):1439-40. PubMed ID: 22887973 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]